BioSpace News Archive

Biotech Beach

Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Life Sciences and MedTech Investor Forum, which takes place March 22-23, 2022.

March 9, 2022
·
3 min read
Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in hemophilia A, demonstrating superiority to prior factor prophylaxis treatment

Sanofi and Swedish Orphan Biovitrum AB announced positive topline results from the pivotal XTEND-1 Phase 3 study evaluating the safety, efficacy and pharmacokinetics of efanesoctocog alfa in previously treated patients ≥12 years of age with severe hemophilia A.

March 9, 2022
·
9 min read
Sequana Medical to Present at BioCapital Europe and Oppenheimer’s Annual Healthcare Conference

Sequana Medical NV, an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces that Ian Crosbie, Chief Executive Officer, will present at the following upcoming investor conferences in March 2022.

March 9, 2022
·
4 min read
Drug Development

Nordic Nanovector Announces Presentation of Preclinical Data on Alpha37, at the American Association for Cancer Research 2022 Annual Meeting

Nordic Nanovector ASA announces that an E-poster regarding Alpha37, entitled “Targeted alpha therapy with 212Pb-NNV003 in treatment of NHL”, will be presented at the 2022 American Association of Cancer Research Annual Meeting held 8-13 April in New Orleans, USA.

March 9, 2022
·
4 min read
Drug Development

iOnctura to Present Preclinical Data on its Clinical Stage Autotaxin Inhibitor, IOA-289, at AACR

iOnctura SA will present preclinical data on its next-generation autotaxin inhibitor, IOA-289, at the annual meeting of the American Association for Cancer Research taking place on April 8-13, 2022 in New Orleans, Louisiana.

March 9, 2022
·
2 min read
Drug Development

Transgene to Present New Positive Preliminary Phase I Data on TG4050 (myvac® platform), its Individualized Therapeutic Cancer Vaccine, at AACR 2022

Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer will be presenting a poster with new and promising preliminary Phase I data on TG4050, its individualized neoantigen cancer vaccine, at the AACR Annual Meeting 2022.

March 9, 2022
·
7 min read
Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule

Midatech Pharma PLC, a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce an extension of its existing R&D collaboration with Janssen Pharmaceutica NV originally announced on 21 July 2020.

March 9, 2022
·
4 min read
Genetown

Presentation of Biomarker Data at AACR - Mar 09, 2022

Faron Pharmaceuticals Ltd announces that an analysis of biomarker data from patients treated with bexmarilimab as part of the ongoing phase I/II MATINS trial, will be presented at the upcoming American Association for Cancer Research Annual Meeting being held in New Orleans, US, from April 8 - 13, 2022.

March 9, 2022
·
11 min read
Pharm Country

West to Participate in Upcoming Investor Conference

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum taking place virtually on March 23, 2022.

March 9, 2022
·
1 min read
Business

Chemomab Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update

Chemomab Therapeutics, Ltd. announced financial and operating results for the fourth quarter and year ended December 31, 2021, and provided a corporate update.

March 9, 2022
·
14 min read